New Delhi: The only weapon in the corona fight is the vaccine. The emphasis has been on vaccination to kill the virus. Oxford’s Covishield and Bharat Biotech’s co-vaccine are being given in India to protect the people. Both of these life-saving antidotes are made in India. However, the Russian vaccine Sputnik V has been cleared by DCGI. India has received approval to distribute Dr. Reddy’s Lab (DRL) for emergency use. Russia’s Gamaleya Institute of Virology reports that the Sputnik V clinical trial showed a 91.8 percent efficacy. The vaccine is also officially called Gam-Covid-Vac.

All of the approved vasosins worldwide require two doses. But another Russian vaccine, Sputnik Light, will do wonders in a single dose, researchers claim. The one-dose vaccine, known as Sputnik Light, can be given to twice as many people at once in a large population like India. As a result, vaccine speed will increase. In May, Sputnik Light was approved for emergency use in Russia. The effectiveness of this vaccine is 84.9 percent. India is in talks to approve its emergency use.

The vaccine was developed using adenovirus as a vector. When it enters the body, it produces corona-like spike proteins that boost the body’s immune system. The protein that Sputnik virus makes contains genetic information. When this protein is found, the body’s immune cells become active. Recognizes what an infectious viral protein looks like and develops the right immunity. Sputnik Light works in a similar design and uses adenoviruses as vectors to connect spikes carrying codes of proteins.

According to initial reports, two doses of Sputnik V were given at 21-day intervals. The Gamalea Institute announced that the two-dose efficacy of Sputnik V is 91 percent, and the efficacy after taking the first dose is 69.4 percent. However, it is not clear how long it will last. The vaccine has been approved for emergency use in 75 countries except India. However, according to the report, it is not very effective in the case of South African variant. Kirill Dimitriev, head of the Russian Direct Investment Fund, claims that Sputnik Light works on all variants.

Sputnik V, launched by DRL in May, is priced at Rs 948 per dose, including GST at Rs 995.50. The second most expensive vaccine. Sputnik Lite, on the other hand, which has not been approved in India, is still priced at around Rs 730 in Indian currency at around ড 10.